Skip to main content
Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
14.23
+1.05 (7.97%)
At close: Jun 6, 2025, 4:00 PM
14.59
+0.36 (2.53%)
After-hours: Jun 6, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Transformative Cell and Exosome-based Therapeutics
25.18M
Log In
Log In
Log In
Log In
Upgrade
Transformative Cell and Exosome-based Therapeutics Growth
886.81%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
25.18M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
886.81%
Log In
Log In
Log In
Log In
Upgrade